Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis
European Journal of Cancer · 2025-12 · 231 · 116092
DOI: 10.1016/j.ejca.2025.116092 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Cancer, 2025-12. Verfasst von Giacomo Bregni und 17 weiteren Autor:innen. Beteiligte Einrichtung: Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Hepatectomy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: European Organisation for Research and Treatment of Cancer.
Themen: Onkologische Pflege
Abstract (Originalsprache)
INTRODUCTION: The role of systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases (CRCLM) is debated. MATERIAL AND METHODS: After a systematic search in PubMed and EMBASE databases, we conducted a meta-analysis of individual patient data from randomised phase III trials comparing surgery plus systemic chemotherapy with surgery alone in patients with CRCLM. Analyses were performed in the overall intention-to-treat (ITT) population, in patients who had curative-intent surgery (resected population), and in those who received post-operative chemotherapy only. The primary endpoint was progression-free survival (PFS). RESULTS: 821 patients (411 surgery alone, 410 surgery plus systemic chemotherapy) from four trials (EORTC 40983/EPOC, FFCD-ACHBTH-AURC 9002, ENG, and UMIN C000000013) were included. Systemic chemotherapy improved PFS in the overall ITT (HR 0.79; 95 %CI: 0.67-0.93, p = 0.004), in the resected (HR 0.77; 95 %CI: 0.65-0.91, p = 0.003) and in the post-operative chemotherapy only (HR 0.76; 95 %CI: 0.61-0.95, p = 0.016) populations. Systemic chemotherapy also improved overall survival (OS) in the overall ITT (HR 0.82; 95 %CI: 0.68-1.0, p = 0.048) and in the resected (HR 0.81; 95 %CI: 0.66-1.00, p = 0.046) populations. After adjusting for prognostic factors in multivariable analyses, the effect of systemic chemotherapy remained significant for PFS in the overall ITT (p < 0.001) and in the post-operative chemotherapy only (p = 0.003) populations. An interaction between systemic chemotherapy and time to diagnosis of liver metastases for PFS was found in the overall ITT (p = 0.027) and in the resected (p = 0.024) populations. CONCLUSIONS: Systemic chemotherapy improves PFS of patients with resectable or resected CRCLM. This effect is stronger for patients with synchronous metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium.
- EORTC AISBL/IVZW - European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
- Saitama Medical Center, Saitama Medical University, Saitama, Japan.
- Japan Institute for Health Security, Shinjuku-ku, Japan.
- The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
- Hopital Saint Louis AP-HP, Paris, France.
Förderung
- European Organisation for Research and Treatment of Cancer
Zitieren
APA
Bregni, G., Leurquin, B., Giasafaki, P., Takemura, N., Kokudo, N., Hasegawa, K., Matsuyama, Y., Nishioka, Y., Aparicio, T., Guimbaud, R., Malicot, K. L., Tu, D., O'Callaghan, C., Lutz, M. P., Fontana, E., Moehler, M., Mauer, M. E., & Sclafani, F. (2025). Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis. European Journal of Cancer, 231, 116092. https://doi.org/10.1016/j.ejca.2025.116092
Vancouver
Bregni G, Leurquin B, Giasafaki P, Takemura N, Kokudo N, Hasegawa K, et al. Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis. European Journal of Cancer. 2025;231:116092. doi:10.1016/j.ejca.2025.116092
BibTeX
@article{Bregni2025,
author = {Bregni, Giacomo and Leurquin, Bryan and Giasafaki, Peggy and Takemura, Nobuyuki and Kokudo, Norihiro and Hasegawa, Kiyoshi and Matsuyama, Yutaka and Nishioka, Yujiro and Aparicio, Thomas and Guimbaud, Rosine and Malicot, Karine Le and Tu, Dongsheng and O'Callaghan, Chris and Lutz, Manfred P and Fontana, Elisa and Moehler, Markus and Mauer, Murielle E and Sclafani, Francesco},
title = {Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis},
journal = {European Journal of Cancer},
year = {2025},
volume = {231},
pages = {116092},
doi = {10.1016/j.ejca.2025.116092}
}
EUVIMED